1. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge
    Omar Castillo-Aguilera et al, 2017, Biomolecules CrossRef
  2. miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
    Andrea Mathe et al, 2015, IJMS CrossRef
  3. The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells
    Penn Muluhngwi et al, 2017, Sci Rep CrossRef
  4. MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis
    Saeideh Jafarinejad-Farsangi et al, 2015, Autoimmunity CrossRef
  5. Altered microRNA expression patterns during the initiation and promotion stages of neonatal diethylstilbestrol-induced dysplasia/neoplasia in the hamster (Mesocricetus auratus) uterus
    Ramesh Padmanabhan et al, 2017, Cell Biol Toxicol CrossRef
  6. miR-29 Regulates Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa
    Michael Vanden Oever et al, 2016, Journal of Investigative Dermatology CrossRef
  7. Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development
    Liliana Guerra et al, 2017, Matrix Biology CrossRef
  8. Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma
    Keiichi Koshizuka et al, 2017, Cancer Metastasis Rev CrossRef
  9. Targeting miRNAs by polyphenols: Novel therapeutic strategy for cancer
    Kasi Pandima Devi et al, 2017, Seminars in Cancer Biology CrossRef
  10. β-catenin downregulates Dicer to promote ovarian cancer metastasis
    S K Y To et al, 2017, Oncogene CrossRef
  11. Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.
    Yuliya Klymenko et al, 2017, Cancers (Basel) CrossRef
  12. Therapeutic targeting of non-coding RNAs in cancer.
    Ondrej Slaby et al, 2017, Biochem J CrossRef
  13. Oxymatrine suppresses proliferation and facilitates apoptosis of human ovarian cancer cells through upregulating microRNA-29b and downregulating matrix metalloproteinase-2 expression
    JINGWEI LI et al, 2015 CrossRef
  14. MicroRNA-29a/b/c targets iNOS and is involved in protective remote ischemic preconditioning in an ischemia-reperfusion rat model of non-alcoholic fatty liver disease
    Yun-Fei Duan et al, 2017 CrossRef
  15. ‘Micro-managers’ of hepatic lipid metabolism and NAFLD
    Wei Liu et al, 2015, WIREs RNA CrossRef
  16. Micro-Economics of Apoptosis in Cancer: ncRNAs Modulation of BCL-2 Family Members
    Lidia Villanova et al, 2018, IJMS CrossRef
  17. MiRNA-Regulated Changes in Extracellular Matrix Protein Levels Associated With a Severe Decline in Lung Function Induced by Silica Dust
    Yi Rong et al, 2018, Journal of Occupational and Environmental Medicine CrossRef
  18. Prognostic biomarkers for cholangiocarcinoma and their clinical implications
    Charupong Saengboonmee et al, 2018, Expert Review of Anticancer Therapy CrossRef
  19. Integration of miRNA weighted gene co-expression network and miRNA-mRNA co-expression analyses reveals potential regulatory functions of miRNAs in calf rumen development
    Duy N. Do et al, 2018, Genomics CrossRef
  20. Regulation of Cancer Immune Escape: The Roles of miRNAs in Immune Checkpoint Proteins
    Qin Yang et al, 2018, Cancer Letters CrossRef
  21. Expression and prognostic value of miRNA-29b in peripheral blood for endometrial cancer
    Hui Wang et al, 2018, Future Oncology CrossRef
  22. Suppressive and Hypermethylated MicroRNAs in the Pathogenesis of Breast Cancer
    V. I. Loginov et al, 2018, Russ J Genet CrossRef
  23. Altered Expression of miRNAs Is Related to Larynx Cancer TNM Stage and Patients' Smoking Status.
    Antoni Bruzgielewicz et al, 2017, DNA Cell Biol CrossRef
  24. miRNA29 Promotes Viral Replication During Early Stage of PRRSV Infection In Vitro
    Mengjiao Zhou et al, 2016, DNA and Cell Biology CrossRef
  25. MiR-29a Inhibits Glioma Tumorigenesis through a Negative Feedback Loop of TRAF4/Akt Signaling
    Yongjie Liu et al, 2018, BioMed Research International CrossRef
  26. Downregulation of long noncoding RNA Sox2ot protects PC-12 cells from hydrogen peroxide-induced injury in spinal cord injury via regulating the miR-211-myeloid cell leukemia-1 isoform2 axis
    Dong Yin et al, 2018, J Cell Biochem CrossRef
  27. The Network of Non-coding RNAs in Cancer Drug Resistance
    Fabio Corrà et al, 2018, Front. Oncol. CrossRef
  28. Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
    Yasutaka Yamada et al, 2018, Int J Urol CrossRef
  29. Aberrant miRNAs expressed in HER-2 negative breast cancers patient
    Cornelia Braicu et al, 2018, J Exp Clin Cancer Res CrossRef
  30. miRNA arm switching identifies novel tumour biomarkers
    Liang Chen et al, 2018, EBioMedicine CrossRef
  31. Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication
    Carolyn Klinge, 2018, ncRNA CrossRef
  32. Metabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotaxin–lysoPA axis in COPD
    Shama Naz et al, 2017, Eur Respir J CrossRef
  33. Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response
    Christin Lund-Andersen et al, 2019, Cold Spring Harb Mol Case Stud CrossRef
  34. Evidence That Up-Regulation of MicroRNA-29 Contributes to Postnatal Body Growth Deceleration.
    Fariha Kamran et al, 2015, Mol. Endocrinol. CrossRef
  35. Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma
    Ichiro Fukumoto et al, 2016, J Hum Genet CrossRef
  36. Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.
    Sasagu Kurozumi et al, 0 CrossRef
  37. The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma
    Keiichi Koshizuka et al, 2017, J Hum Genet CrossRef
  38. Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells
    Penn Muluhngwi et al, 2017, Cancer Letters CrossRef
  39. Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas.
    Shuhei Osaki et al, 2016, Sci Rep CrossRef
  40. Recombinant pre-miR-29b for Alzheimer´s disease therapeutics
    Patrícia A. Pereira et al, 2016, Sci Rep CrossRef
  41. Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver
    C. Lisa Kurtz et al, 2015, Sci Rep CrossRef
  42. Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells
    Abu Musa Md Talimur Reza et al, 2016, Sci Rep CrossRef
  43. TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression
    Ken-ichi Takayama et al, 2015, Nat Commun CrossRef
  44. A therapeutic approach towards microRNA29 family in vascular diabetic complications: A boon or curse?
    Aishwarya P. Dasare et al, 2019, J Diabetes Metab Disord CrossRef
  45. MicroRNA roles in signalling during lactation: an insight from differential expression, time course and pathway analyses of deep sequence data
    Duy N. Do et al, 2017, Sci Rep CrossRef
  46. Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer
    Shan-Ju Yeh et al, 2019, IJMS CrossRef
  47. miR-29c overexpression and COL4A1 downregulation in infertile human endometrium reduces endometrial epithelial cell adhesive capacity in vitro implying roles in receptivity.
    Evdokia Dimitriadis, 0 CrossRef
  48. Dextran-coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell line
    Serap Yalcin, 2019, Pharmaceutical Development and Technology CrossRef
  49. Dysregulation of helper T lymphocytes in esophageal squamous cell carcinoma (ESCC) patients is highly associated with aberrant production of miR-21
    Hadiseh Samiei et al, 2019, Immunol Res CrossRef
  50. Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine
    Li-juan Tang et al, 2019, Cancer Cell Int CrossRef
  51. Integrated analyses of microRNA-29 family and the related combination biomarkers demonstrate their widespread influence on risk, recurrence, metastasis and survival outcome in colorectal cancer
    Qiliang Peng et al, 2019, Cancer Cell Int CrossRef
  52. miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3.
    Bao Zhang et al, 2019, Biol Res CrossRef
  53. Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis
    Ian J. Purvis et al, 2019, JCM CrossRef
  54. Emerging molecular markers for the prognosis of differentiated thyroid cancer patients
    Enke Baldini et al, 2014, International Journal of Surgery CrossRef
  55. MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6
    Hye Sook Han et al, 2014 CrossRef
  56. Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ)
    Heng-Jia Liu et al, 2019, Oncogene CrossRef
  57. MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability
    Hongkai Zhang et al, 2015, Med Oncol CrossRef
  58. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
    Eleni van Schooneveld et al, 0 CrossRef
  59. Nidogen-1 is a common target of microRNAs MiR-192/215 in the pathogenesis of Hirschsprung's disease
    Dongmei Zhu et al, 2015, J. Neurochem. CrossRef
  60. Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review.
    Saira R Ali et al, 0 CrossRef
  61. Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
    Giulia De Falco et al, 2015, BMC Cancer CrossRef
  62. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3
    Rui Li et al, 2016, Tumor Biol. CrossRef
  63. Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells
    Dianke Yu et al, 2015, Biochemical Pharmacology CrossRef
  64. The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment
    Ken-ichi Takayama et al, 2016, Briefings in Functional Genomics CrossRef
  65. IGF1 3′UTR functions as a ceRNA in promoting angiogenesis by sponging miR-29 family in osteosarcoma
    Shuming Gao et al, 2016, J Mol Hist CrossRef
  66. The Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic Diseases
    Praveen Sethupathy, 2016, Curr Diab Rep CrossRef
  67. MicroRNA hsa-miR-29b potentiates etoposide toxicity in HeLa cells via down-regulation of Mcl-1
    S. Kollinerová et al, 2017, Toxicology in Vitro CrossRef
  68. Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c
    Altay Burak Dalan et al, 2017, BMC Cancer CrossRef
  69. null
    Ken-ichi Takayama et al, 2017 CrossRef
  70. Cross disease analysis of co-functional microRNA pairs on a reconstructed network of disease-gene-microRNA tripartite
    Hui Peng et al, 2017, BMC Bioinformatics CrossRef
  71. Sinomenine restrains breast cancer cells proliferation, migration and invasion via modulation of miR-29/PDCD-4 axis
    Guanglei Gao et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  72. null
    Kamila Souckova et al, 2020 CrossRef
  73. Novel miR-29b target regulation patterns are revealed in two different cell lines
    Wenting Zhao et al, 2019, Sci Rep CrossRef
  74. Inflammation related miRNAs as an important player between obesity and cancers
    Morteza Gholami et al, 2019, J Diabetes Metab Disord CrossRef
  75. miR-29b inhibits non-small cell lung cancer progression by targeting STRN4
    Yuping Xie et al, 2019, Human Cell CrossRef
  76. null
    Sepideh Shahkarami et al, 2020 CrossRef
  77. Enrichment of Up-regulated and Down-regulated Gene Clusters Using Gene Ontology, miRNAs and lncRNAs in Colorectal Cancer
    Fahimeh Fattahi et al, 2019, CCHTS CrossRef
  78. MFAP2 is overexpressed in gastric cancer and promotes motility via the MFAP2/integrin α5β1/FAK/ERK pathway
    Li-wen Yao et al, 2020, Oncogenesis CrossRef
  79. WGCNA Co-Expression Network Analysis Reveals ILF3-AS1 Functions as a CeRNA to Regulate PTBP1 Expression by Sponging miR-29a in Gastric Cancer
    Zhen-Hu Ren et al, 2020, Front. Genet. CrossRef
  80. miR-29b and retinoic acid co-delivery: a promising tool to induce a synergistic antitumoral effect in non-small cell lung cancer cells
    Mariana Magalhães et al, 2020, Drug Deliv. and Transl. Res. CrossRef
  81. miR-29a regulated ER-positive breast cancer cell growth and invasion and is involved in the insulin signaling pathway
    Zhi-hua Li et al, 2017, Oncotarget CrossRef
  82. Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients
    Aleksandra Butrym et al, 2016, Oncotarget CrossRef
  83. MiR-29b/TET1/ZEB2 signaling axis regulates metastatic properties and epithelial-mesenchymal transition in breast cancer cells.
    Hua Wang et al, 0 CrossRef
  84. MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia
    Chiranjib Chakraborty et al, 2106, Oncotarget CrossRef
  85. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells
    Xiaoxin Shi et al, 2020, European Journal of Pharmacology CrossRef
  86. Determination of novel biomarkers and pathways shared by colorectal cancer and endometrial cancer via comprehensive bioinformatics analysis
    Foyzur Rahman et al, 2020, Informatics in Medicine Unlocked CrossRef
  87. Regulation of breast cancer metastasis signaling by miRNAs
    Belinda J. Petri et al, 2020, Cancer Metastasis Rev CrossRef
  88. The role of miR-29a in HIV-1 replication and latency
    Giacomo Frattari et al, 2017, Journal of Virus Eradication CrossRef
  89. miR‑29a‑3p represses proliferation and metastasis of gastric cancer cells via attenuating HAS3 levels
    Feihu Bai et al, 2018, Mol Med Report CrossRef
  90. Knockdown of microRNA‑29a regulates the expression of apoptosis‑related genes in MCF‑7 breast carcinoma cells
    Gholamreza Khamisipour et al, 2017, mol clin onc CrossRef
  91. miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1
    Jin Liu et al, 2018, Int J Oncol CrossRef
  92. Identification of six key miRNAs associated with breast cancer through screening large‑scale microarray data
    Faqing Liang et al, 2018, Oncol Lett CrossRef
  93. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways
    Kurt Sartorius et al, 2020, Viruses CrossRef
  94. LncRNA H19 Overexpression Activates Wnt Signaling to Maintain the Hair Follicle Regeneration Potential of Dermal Papilla Cells
    Ningxia Zhu et al, 2020, Front. Genet. CrossRef
  95. Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from Gastric Cancer
    Hideyuki Ohzawa et al, 2020, Ann Surg Oncol CrossRef
  96. Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA
    Iwona Sidorkiewicz et al, 2020, Cancers CrossRef
  97. miR-29a-5p Regulates the Proliferation, Invasion, and Migration of Gliomas by Targeting DHRS4
    Yong Dai et al, 2020, Front. Oncol. CrossRef
  98. Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies.
    Subhasree Kumar et al, 2020, Cancers (Basel) CrossRef
  99. A genome-wide association study to identify candidate genes for erectile dysfunction
    Elham Kazemi et al, 2020 CrossRef
  100. Differences of time-dependent microRNA expressions in breast cancer cells
    Serife Buket Bozkurt et al, 2020, Non-coding RNA Research CrossRef
  101. miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL Study
    Loki Natarajan et al, 2019, Cancer Epidemiol Biomarkers Prev CrossRef
  102. CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors
    Mohit Jain et al, 2021, Chromosome Res CrossRef
  103. Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells
    Przemysław A. Stempor et al, 2021, IJMS CrossRef
  104. Dual Effect of Taxifolin on ZEB2 Cancer Signaling in HepG2 Cells
    Zdenek Dostal et al, 2021, Molecules CrossRef
  105. null
    Xinzhi Qiu et al, 2021 CrossRef
  106. Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p
    Pauline Rozier et al, 2021, Journal of Autoimmunity CrossRef
  107. miR-29a/b1 Regulates the Luteinizing Hormone Secretion and Affects Mouse Ovulation
    Yang Guo et al, 2021, Front. Endocrinol. CrossRef
  108. Co-Deregulated miRNA Signatures in Childhood Central Nervous System Tumors: In Search for Common Tumor miRNA-Related Mechanics
    George I. Lambrou et al, 2021, Cancers CrossRef
  109. Interferon-γ: teammate or opponent in the tumour microenvironment?
    Angela M. Gocher et al, 2021, Nat Rev Immunol CrossRef
  110. Sufentanil Inhibits Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells by Upregulating miRNA-204
    Jiuwu Zhuo et al, 2021, j biomater tissue eng CrossRef
  111. MicroRNA miR-29c regulates RAG1 expression and modulates V(D)J recombination during B cell development.
    Rupa Kumari et al, 2021, Cell Rep CrossRef
  112. Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells
    Penn Muluhngwi et al, 2021, Cancers CrossRef
  113. Correntropy-Based Hypergraph Regularized NMF for Clustering and Feature Selection on Multi-Cancer Integrated Data
    Na Yu et al, 2021, IEEE Trans. Cybern. CrossRef
  114. Age-associated changes in microRNAs affect the differentiation potential of human mesenchymal stem cells: Novel role of miR-29b-1-5p expression
    Nada H. Eisa et al, 2021, Bone CrossRef
  115. Characterization of microRNA expression in B cells derived from Japanese black cattle naturally infected with bovine leukemia virus by deep sequencing
    Chihiro Ochiai et al, 2021, PLoS ONE CrossRef
  116. Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects
    Yu Zhang et al, 2021, Front. Oncol. CrossRef
  117. LentiRILES, a miRNA-ON sensor system for monitoring the functionality of miRNA in cancer biology and therapy
    Viorel Simion et al, 2021, RNA Biology CrossRef
  118. MicroRNA Therapeutics in Triple Negative Breast Cancer
    Sarmistha Mitra, 2017, Arch Pathol Clin Res CrossRef
  119. null
    Debduti Datta et al, 2022 CrossRef
  120. MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial–mesenchymal transition (MMT) of human peritoneal mesothelial cells
    Yuki Kimura et al, 2022, Sci Rep CrossRef
  121. MiRNA–disease association prediction based on meta-paths
    Liang Yu et al, 2022 CrossRef
  122. Invading, Leading and Navigating Cells in Caenorhabditis elegans: Insights into Cell Movement in Vivo
    David R Sherwood et al, 2018 CrossRef
  123. null
    Forough Hakiminia et al, 2021 CrossRef
  124. Non-Exosomal and Exosome-Derived miRNAs as Promising Biomarkers in Canine Mammary Cancer
    Patrícia Petroušková et al, 2022, Life CrossRef
  125. Joint Effects of Cigarette Smoking and Green Tea Consumption with miR-29b and DNMT3B mRNA Expression in the Development of Lung Cancer
    Chia-Chen Huang et al, 2022, Genes CrossRef
  126. Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer
    Radu Pirlog et al, 2022, IJMS CrossRef
  127. MicroRNA-29 Ameliorates Fibro-Inflammation and Insulin Resistance in HIF1α-Deficient Obese Adipose Tissue by Inhibiting Endotrophin Generation
    Woobeen Jo et al, 2022 CrossRef
  128. Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs
    Arsinoe C. Thomaidou et al, 2022, IJMS CrossRef
  129. miR‑29b‑3p inhibits 22Rv1 prostate cancer cell proliferation through the YWHAE/BCL‑2 regulatory axis
    Jiafu Zhao et al, 2022, Oncol Lett CrossRef
  130. Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches
    Silvia Grassilli et al, 2022, Diagnostics CrossRef
  131. null
    Debduti Datta et al, 2022 CrossRef
  132. A perspective to weaponize microRNAs against lung cancer
    Dhanashree Murugan et al, 2022, Non-coding RNA Research CrossRef
  133. Identification of neoplasm-specific signatures of miRNA interactions by employing a systems biology approach
    Reza Arshinchi Bonab et al, 2022 CrossRef
  134. A cellular regulator of the niche: telocyte
    Sena Babadag et al, 2022, Tissue Barriers CrossRef
  135. Identification of oncogenic signatures in the inflammatory colon of C57BL/6 mice fed a high fat diet
    Huawei Zeng et al, 2022, The Journal of Nutritional Biochemistry CrossRef
  136. pH-responsive nanoparticles based on POEOMA-b-PDPA block copolymers for RNA encapsulation, protection and cell delivery
    Bruno Baptista et al, 2022, Biomaterials Advances CrossRef
  137. Diagnostic Value of Potential MicroRNAs in CRC: A Meta-Analysis
    Sofia Fathi et al, 2022, MIRNA CrossRef
  138. The Emerging Role of Epigenetics in Metabolism and Endocrinology
    Belay Zeleke Sibuh et al, 2023, Biology CrossRef
  139. Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer
    Mingliang Zhang et al, 2016 CrossRef
  140. Intraperitoneal transfer of microRNA‐29b‐containing small extracellular vesicles can suppress peritoneal metastases of gastric cancer
    Yuki Kimura et al, 2023, Cancer Science CrossRef
  141. LncRNA PNKY Is Upregulated in Breast Cancer and Promotes Cell Proliferation and EMT in Breast Cancer Cells
    Forough Hakiminia et al, 2023, ncRNA CrossRef
  142. Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis
    Amir Mokhlesi et al, 2023, Non-coding RNA Research CrossRef
  143. Aberrant expression of miR‐29b‐3p influences heart development and cardiomyocyte proliferation by targeting NOTCH2
    Qian Yang et al, 2020, Cell Proliferation CrossRef
  144. Understanding the lncRNA/miRNA-NFκB regulatory network in diabetes mellitus: From function to clinical translation
    Parisa Hoorzad et al, 2023, Diabetes Research and Clinical Practice CrossRef
  145. Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach
    Seyedehsadaf Asfa et al, 2023, IJERPH CrossRef
  146. Evaluation of the Potential Diagnostic Role of the Lnc-MIAT, miR-29a-3p, and FOXO3a ceRNA Networks as Noninvasive Circulatory Bioindicator in Ductal Carcinoma Breast Cancer
    Shokufeh Razi et al, 2023, Breast Cancer�(Auckl) CrossRef
  147. Restoration of Altered Oncogenic and Tumor Suppressor microRNA Expression in Breast Cancer and Colorectal Cancer Cell using Epicatechin
    Sheetal Kiran et al, 2023, CMP CrossRef
  148. null
    S. Sriharikrishnaa et al, 2023 CrossRef
  149. A comprehensive review of the biomaterial-based multifunctional nanocarriers for therapeutic applications in breast cancer
    Arti Shettiwar et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
  150. Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer
    Hasan Mollanoori et al, 2024, Sci Rep CrossRef
  151. Deregulation of miR‐1245b‐5p and miR‐92a‐3p and their potential target gene, GATA3, in epithelial–mesenchymal transition pathway in breast cancer
    Mahtab Yadollahi Farsani et al, 2024, Cancer Reports CrossRef
  152. miR-29a-3p orchestrates key signaling pathways for enhanced migration of human mesenchymal stem cells
    Dayeon Kang et al, 2024, Cell Commun Signal CrossRef
  153. Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
    Anshika Jangra et al, 2022, Cells CrossRef
  154. miR-29 is an important driver of aging-related phenotypes
    Vijay Swahari et al, 2024, Commun Biol CrossRef
  155. On the mechanism of miR-29b enhancement of etoposide toxicity in vitro
    Zdeněk Dostál et al, 2024, Sci Rep CrossRef
  156. MicroRNAs and human viral diseases: A focus on the role of microRNA-29
    Mina Mobini Kesheh et al, 2025, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  157. Micro-RNAs in Breast Cancer Progression and Metastasis: A Chromatin and Metabolic Perspective.
    Sweta Sikder et al, 2024, Heliyon CrossRef